Trade Summary

3 days ago, Saad Mark E, serving as Dir at Axsome Therapeutics, Inc. (AXSM), sold 37,577 shares at $165.18 per share, for a total transaction value of $6,206,969.00. Following this transaction, Saad Mark E now holds 10,302 shares of AXSM.

This sale represents a 78.00% decrease in Saad Mark E's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, December 31, 2025 and publicly disclosed via SEC Form 4 filing on Friday, January 2, 2026, 2 days after the trade was made.

Axsome Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.